Markets:

Overview

News

Currencies

International

Treasuries

Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.150 -0.030 (-2.54%)

Streaming Delayed Price Updated: 10:17 AM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biomea Fusion, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population

July 24, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Are (More) Big Gains Ahead for This Small Cap Biotech Stock?

June 28, 2023

With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.

Via MarketBeat

Topics Initial Public Offering

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Biomea Fusion, Inc. and Encourages Investors with Losses to Contact the Firm

June 27, 2023

From The Schall Law Firm

Via Business Wire

What 18 Analyst Ratings Have To Say About Biomea Fusion ↗

June 26, 2023

Via Benzinga

Analyst Ratings for Biomea Fusion ↗

May 18, 2023

Via Benzinga

Recap: Biomea Fusion Q1 Earnings ↗

May 02, 2023

Via Benzinga

Analyst Ratings for Biomea Fusion ↗

April 19, 2023

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biomea Fusion, Inc. and Encourages Investors with Losses to Contact the Firm

June 26, 2023

From The Schall Law Firm

Via Business Wire

Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet ↗

June 26, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,...

Via Benzinga

Crude Oil Rises; Carnival Shares Drop After Q2 Results ↗

June 26, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also...

Via Benzinga

Biomea Fusion Stock Is Trading Higher Today - Here's Why ↗

June 26, 2023

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first two cohorts from the Phase 2 portion of its ongoing Phase 1/2 clinical study (COVALENT-111) of BMF-219...

Via Benzinga

Why Biomea Fusion Stock Crushed It This Week ↗

March 30, 2023

A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.

Via The Motley Fool

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 26, 2023

It's time to start off the week right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

Biomea Fusion Presents Positive Clinical Data from the Initial Cohorts of the Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes Mellitus at the American Diabetes Association (ADA) 83rd Scientific Sessions; 100 mg Cohort 3

June 23, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes at ADA 2023

June 20, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights

May 02, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia

May 01, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes, at the ADA 83rd Scientific Sessions 2023 in June

April 19, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting

April 13, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

April 13, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

These 5 High-Growth Small-Cap Stocks Surged More Than 100% In Q1: What's Next? ↗

April 05, 2023

The S&P 500 index, which is tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), posted a gain of 6.2% in the first quarter of 2023, while technology stocks in the Nasdaq 100 index, which is tracked by...

Via Benzinga

$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 04, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock

March 29, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Is Cathie Wood Giving Up on Xpeng (XPEV) Stock? ↗

March 29, 2023

Investors in Xpeng (XPEV) are wondering if Cathie Wood is giving up on the stock after a recent selloff during a strong rally.

Via InvestorPlace

What's Going On With Biomea Fusion Stock? ↗

March 29, 2023

Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher. The company reported fourth-quarter results after the bell and announced an offering Wednesday morning. Several analysts are out with...

Via Benzinga

Dear SBNY Stock Fans, Mark Your Calendars for April 5 ↗

March 29, 2023

Fans of Signature Bank (SBNY) stock will want to keep an eye on the financial company for a catalyst when April 5 rolls around.

Via InvestorPlace

BMEA Stock: Biomea Fusion Pops on Public Offering News ↗

March 29, 2023

Biomea Fusion (BMEA) stock is climbing higher on Wednesday after the company announced a public offering plan and continues a recent rally.

Via InvestorPlace

Biomea Fusion Announces Proposed Public Offering of Common Stock

March 29, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.